Clinical Trials Directory

Trials / Completed

CompletedNCT02451072

The Role of 5-HT2A Receptor in the Perception of Self and Personal Meaning in Healthy Volunteers

The Role of 5-HT2A Receptor on Perception of the Self and Perception of Meaning in Healthy Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Psychiatric University Hospital, Zurich · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Aim of the present study is to investigate the neuronal correlates of self and of personal meaning as well as the role of the serotonin (5-HT) 2A receptor system in these processes using functional magnetic resonance imaging (fMRI) and psychometric and cognitive measures.

Detailed description

The present study aims at identifying the contribution of the 5-HT2A receptor system to the formation of self and personal meaning in normal and altered states of consciousness. Specifically, the effect of the 5-HT2/1/6/7 receptor agonist lysergic acid diethylamide (LSD) on self-consciousness, perception and the making of meaning will be assessed in 25 healthy subjects using a randomized, placebo-controlled, double blind, cross-over design. Furthermore, the contribution of the 5-HT2A receptor to these functions shall be assessed by pretreatment with the specific 5-HT2A antagonist ketanserin.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboCapsules containing mannitol looking identical to LSD per os
DRUGLSD100µg per os, single dose
DRUGKetanserin40mg per os, single dose looking identical to LSD per os

Timeline

Start date
2015-03-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-05-21
Last updated
2016-02-01

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02451072. Inclusion in this directory is not an endorsement.